Double maintains 2 strategies that include EYPT - EyePoint Pharmaceuticals, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -16.06% | $22.95B | +20.67% | 1.12% |
FMTO | -13.09% | $45.74M | -99.96% | 0.00% |
ED | -10.80% | $36.75B | +5.26% | 3.28% |
DOGZ | -9.42% | $231.95M | +120.05% | 0.00% |
LITB | -8.59% | $21.28M | -72.45% | 0.00% |
MO | -8.38% | $97.80B | +26.35% | 6.94% |
T | -7.61% | $196.66B | +57.98% | 4.07% |
PM | -7.37% | $263.27B | +68.03% | 3.17% |
VHC | -6.86% | $34.69M | +74.89% | 0.00% |
AEP | -6.58% | $54.28B | +9.80% | 3.61% |
KMB | -6.50% | $45.57B | +1.99% | 3.58% |
VSA | -6.07% | $7.04M | -49.24% | 0.00% |
CME | -5.96% | $98.74B | +28.80% | 3.84% |
K | -5.80% | $28.49B | +32.17% | 2.77% |
DUK | -4.64% | $90.12B | +12.74% | 3.61% |
EXC | -4.36% | $43.84B | +12.45% | 3.59% |
KNOP | -4.18% | $226.71M | +23.32% | 1.57% |
SO | -4.11% | $96.04B | +10.08% | 3.29% |
PULM | -4.08% | $23.82M | +239.64% | 0.00% |
CHD | -4.04% | $23.29B | -11.36% | 1.23% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CMS | -<0.01% | $21.21B | +12.27% | 2.97% |
PHG | 0.02% | $22.46B | -11.58% | 3.69% |
NOC | 0.05% | $67.51B | -0.35% | 1.76% |
NEUE | -0.09% | $62.05M | +13.56% | 0.00% |
MSIF | -0.17% | $715.25M | +28.42% | 7.05% |
PSQH | 0.22% | $89.26M | -49.87% | 0.00% |
CLX | 0.23% | $16.64B | -1.45% | 3.61% |
COR | 0.27% | $55.43B | +28.90% | 0.56% |
GIS | 0.29% | $29.79B | -23.81% | 4.42% |
UNH | 0.33% | $248.87B | -47.37% | 3.06% |
GFL | 0.40% | $17.98B | +53.65% | 0.12% |
CAG | -0.40% | $10.87B | -26.52% | 6.17% |
PPL | -0.53% | $25.45B | +16.24% | 3.04% |
KO | 0.53% | $308.23B | +13.09% | 2.75% |
PEP | -0.56% | $180.30B | -28.19% | 4.14% |
TPB | -0.76% | $1.29B | +113.31% | 0.40% |
ACGL | 0.82% | $35.05B | -0.46% | 0.00% |
PPC | -1.00% | $11.21B | +41.54% | 0.00% |
LFVN | -1.05% | $158.74M | +75.02% | 1.27% |
HRB | -1.08% | $7.60B | +7.02% | 2.55% |
Yahoo
WATERTOWN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an a
Yahoo
WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming investor conferences: RBC Capital Markets Global Healthcare Conference Forum: Fireside ChatDate: Tuesday, May 20, 2025Time: 10:00 a.m. ET Mizuho Neuro & Ophthalmology Summit 202
Yahoo
Celebrations may be in order for EyePoint Pharmaceuticals, Inc. ( NASDAQ:EYPT ) shareholders, with the analysts...
Yahoo
EyePoint Pharmaceuticals, Inc. ( NASDAQ:EYPT ) just released its latest quarterly results and things are looking...
SeekingAlpha
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ETCompany ParticipantsGeorge Elston - Executive Vice...
Yahoo
The headline numbers for EyePoint Pharmaceuticals (EYPT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 57.83% | $4.85B | 0.35% |
GNOM | 57.38% | $40.65M | 0.5% |
ARKG | 57.36% | $944.78M | 0.75% |
IWC | 52.67% | $766.88M | 0.6% |
IBB | 50.36% | $5.22B | 0.45% |
IWO | 50.33% | $11.36B | 0.24% |
IWM | 48.69% | $63.95B | 0.19% |
VTWO | 48.47% | $12.07B | 0.07% |
PTH | 48.14% | $96.56M | 0.6% |
PBE | 47.77% | $214.12M | 0.58% |
KJAN | 47.24% | $305.13M | 0.79% |
XPH | 47.21% | $136.58M | 0.35% |
CPRJ | 46.43% | $48.43M | 0.69% |
SCHA | 46.38% | $16.91B | 0.04% |
KJUL | 46.23% | $113.35M | 0.79% |
GSSC | 45.93% | $538.65M | 0.2% |
KOMP | 45.40% | $2.20B | 0.2% |
NUSC | 45.38% | $1.14B | 0.31% |
IWN | 45.18% | $11.10B | 0.24% |
ISCG | 45.03% | $645.00M | 0.06% |
Current Value
$5.811 Year Return
Current Value
$5.811 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -33.84% | $361.41M | 1.43% |
TAIL | -28.65% | $140.49M | 0.59% |
VIXY | -27.38% | $109.64M | 0.85% |
ULST | -19.84% | $637.77M | 0.2% |
SPTS | -12.11% | $5.76B | 0.03% |
FXY | -11.82% | $838.61M | 0.4% |
UNG | -11.71% | $371.83M | 1.06% |
XONE | -11.49% | $603.24M | 0.03% |
IVOL | -11.22% | $353.94M | 1.02% |
JMST | -11.05% | $3.65B | 0.18% |
TFLO | -11.04% | $7.06B | 0.15% |
TPMN | -11.03% | $31.54M | 0.65% |
AGZ | -10.29% | $607.46M | 0.2% |
XHLF | -10.19% | $1.46B | 0.03% |
IBTG | -10.16% | $1.88B | 0.07% |
SCHO | -9.50% | $10.87B | 0.03% |
FTSD | -9.38% | $212.46M | 0.25% |
CARY | -9.19% | $347.36M | 0.8% |
STPZ | -9.16% | $446.46M | 0.2% |
UTWO | -8.93% | $387.71M | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
OCUL | 60.32% | $1.14B | +14.35% | 0.00% |
BEAM | 55.46% | $1.73B | -27.49% | 0.00% |
NTLA | 52.52% | $836.43M | -69.14% | 0.00% |
ABCL | 52.15% | $602.94M | -46.56% | 0.00% |
RXRX | 51.54% | $1.73B | -55.31% | 0.00% |
DNLI | 51.27% | $2.06B | -30.04% | 0.00% |
CRSP | 50.63% | $3.14B | -34.78% | 0.00% |
RCKT | 48.37% | $724.54M | -71.26% | 0.00% |
RGNX | 47.98% | $433.39M | -46.03% | 0.00% |
IMNM | 47.40% | $696.10M | -44.44% | 0.00% |
NNOX | 46.99% | $347.50M | -44.56% | 0.00% |
KYMR | 46.80% | $1.95B | -15.67% | 0.00% |
ATXS | 46.16% | $225.17M | -57.69% | 0.00% |
ALEC | 45.68% | $110.49M | -79.87% | 0.00% |
VYGR | 45.19% | $181.50M | -61.99% | 0.00% |
ELVN | 44.25% | $874.36M | -25.16% | 0.00% |
CLDX | 44.08% | $1.33B | -49.67% | 0.00% |
SDGR | 43.88% | $1.71B | +2.01% | 0.00% |
CMPS | 43.87% | $366.75M | -50.56% | 0.00% |
FENC | 43.78% | $180.77M | -8.01% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
JSI | -0.05% | $729.68M | 0.49% |
SHAG | 0.13% | $37.97M | 0.12% |
LTPZ | 0.14% | $673.45M | 0.2% |
SCHJ | -0.20% | $515.13M | 0.03% |
GNMA | -0.25% | $355.60M | 0.1% |
YEAR | -0.29% | $1.40B | 0.25% |
FLCB | 0.35% | $2.52B | 0.15% |
SPIP | 0.38% | $984.63M | 0.12% |
AGGH | -0.40% | $309.35M | 0.29% |
SUSB | 0.40% | $967.17M | 0.12% |
BNDX | -0.41% | $64.67B | 0.07% |
TBIL | 0.42% | $5.76B | 0.15% |
IBDS | 0.61% | $3.01B | 0.1% |
BND | -0.70% | $125.46B | 0.03% |
IBDQ | 0.76% | $3.08B | 0.1% |
BAB | 0.83% | $919.66M | 0.28% |
IBMN | -0.90% | $446.12M | 0.18% |
TIP | -0.90% | $13.74B | 0.18% |
SPSK | -0.90% | $307.27M | 0.5% |
AGZD | 0.91% | $127.42M | 0.23% |